About the Company
Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ALCON INC
Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall
Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...
These Analysts Slash Their Forecasts On Alcon After Q2 Earnings
Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
Alcon, Inc. ALC delivered second-quarter 2025 core earnings per share (EPS) of 76 cents, up 2.7% from the year-ago quarter’s ...
Alcon (ALC) Gets Battered by Dismal Earnings, Soft Outlook
We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares ...
Alcon: More Than Meets The Eye
Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds. Read the ...
Alcon’s stock falls as third-quarter sales miss estimates
Alcon Inc. shares ALC dropped more than 4% premarket on Wednesday after the eye care company on Tuesday reported third-quarter revenues below analysts’ expectations. The company reported net ...
Alcon Breaks Above 200-Day Moving Average - Bullish for ALC
In trading on Monday, shares of Alcon Inc (Symbol: ALC) crossed above their 200 day moving average of $89.71, changing hands as high as $90.61 per share. Alcon Inc shares are currently trading up ...
Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens
Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients ...
Why Medical Device Company Alcon Shares Are Sliding Today
Alcon Inc ALC shares are trading lower by around 5% after it reported worse-than-expected Q3 FY23 results. Sales rose 8% Y/Y (+9% Y/Y in constant currencies) to $2.30 billion, missing the ...
Alcon profit powers share price surge - MarketWatch
Alcon, whose majority shareholder is Nestle S.A., late Monday said it made $465.5 million, or $1.50 a share, compared with $325 million, or $1.04 a share, in the same quarter a year earlier.
Alcon (ALC) on Track With Successful Global PRECISION1 Rollout
Alcon Inc ALC maintains a successful rollout of PRECISION1, with spherical lens currently available in key Latin America and Asia markets, and the PRECISION1 for Astigmatism available in Europe.
Similar Companies
| Company | Ticker | 90 Days Forecast | Market Cap. (USD M) | P/E | P/B |
|---|---|---|---|---|---|
| ALCON INC | ALC | Predict | 24078.98 | 10.89 | None |
| Bausch & Lomb Corp | BLCO | Predict | 5198.63 | -15.12 | 0.81 |
| COOPER COMPANIES, INC. | COO | Predict | 14674.09 | 35.43 | 1.77 |
| National Vision Holdings, Inc. | EYE | Predict | 1903.03 | -14.03 | 2.24 |
| Innovative Eyewear Inc | LUCY | Predict | 9.24 | -2.36 | 0.82 |
| Innovative Eyewear Inc | LUCYW | Predict | 0.42 | None | 0.04 |
| RxSight, Inc. | RXST | Predict | 344.90 | -39.76 | 1.24 |
| STAAR SURGICAL CO | STAA | Predict | 1375.89 | 68.04 | 4.09 |
| Warby Parker Inc. | WRBY | Predict | 3339.10 | -68.66 | 9.24 |
Loading the latest forecasts...